Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID‐19 patients

We propose a new hypothesis that the established drug pentoxifylline deserves attention as a potential repurposed therapeutic for COVID‐19. Pentoxifylline is an immunomodulator with anti‐inflammatory properties. It is a nonselective phosphodiesterase inhibitor and through Adenosine A2A Receptor‐medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendry, Bruce M., Stafford, Nina, Arnold, Ahran D., Sangwaiya, Arvind, Manglam, Vijay, Rosen, Stuart D., Arnold, Jayantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383088/
https://www.ncbi.nlm.nih.gov/pubmed/32715661
http://dx.doi.org/10.1002/prp2.631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383088/
https://www.ncbi.nlm.nih.gov/pubmed/32715661
http://dx.doi.org/10.1002/prp2.631

Ejemplares similares